Completed PHASE3 INTERVENTIONAL NCT00215449

Study in Patients With COPD

Sponsor: Dey

Conditions COPD

Updated 5 times since 2017 Last updated: Nov 10, 2010 Primary completion: Dec 31, 2005 Completion: Apr 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on COPD, this trial is completed. The trial is conducted by Dey and has accumulated 5 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Data source: Dey

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Atlanta, United States , Austin, United States , Bay Pines, United States , Bessemer, United States , Birmingham, United States , Blue Ridge, United States , Buena Park, United States , Butte, United States , Chapel Hill, United States and 48 more locations